Details for 2017753704

Up to date per 01.04.2026

Actions

Title / Product Name

VERFAHREN MIT FIXER INTERMITTIERENDER DOSIERUNG VON CEDIRANIB

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017753704

EP Publication Number

3417294

E-Number

1451696

Language

PCT Number

US17017804

Publication Date

26.12.2018 A

01.12.2021 B1

Registration Date

01.12.2021

AT Publication Date

15.12.2021

Application Date

14.02.2017

Registration Number

Priorities

15.02.2016

201662295421 P

IPC

C07K 16/28 20060101AFI20210125BHEP

Maximum Duration of Protection

14.02.2037

Owner

Astrazeneca AB151 85 SödertäljeSE

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH6701 Rockledge Drive, Suite 700, MSC 7788 Bethesda, MD 20892US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

BARRY, Simon Cambridge CB4 0WGGB

KENDREW, Jane Macclesfield Cheshire SK10 4TGGB

HO, Tony Gaithersburg, MD 20878US

WEDGE, Stephen, Robert Granta Park Cambridge CB21 6GHGB

IVY,Susan Percy Bethesda, MD 20892-7660US

KOHN, Elise Bethesda, MD 20892-7660US

LEE, Jung-Min Bethesda, MD 20892-7660US

Information about Fees